United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - chloroprocaine hydrochloride 20 mg in 1 ml - chloroprocaine hydrochloride injection 2% and 3%, in single dose vials, without methylparaben preservative, without edta, is indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. chloroprocaine hydrochloride injection is not to be used for subarachnoid administration. chloroprocaine hydrochloride is contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.

Malta - English - Medicines Authority

bausch health ireland limited 3013 lake drive, citywest business campus, dublin 24, d24ppt3, ireland - oxybuprocaine hydrochloride - eye drops, solution - oxybuprocaine hydrochloride 0.4 percent weight/volume - ophthalmologicals

New Zealand - English - Medsafe (Medicines Safety Authority)

bausch & lomb (nz) ltd - oxybuprocaine hydrochloride 0.4%{relative} - eye drops, solution - 0.4% w/v - active: oxybuprocaine hydrochloride 0.4%{relative} excipient: hydrochloric acid purified water

Malta - English - Medicines Authority

bausch & lomb uk limited - oxybuprocaine hydrochloride - eye drops, solution - oxybuprocaine hydrochloride 0.4 % (w/v) - ophthalmologicals

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - chloroprocaine hydrochloride 10 mg in 1 ml - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block. they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - oxybuprocaine hydrochloride, quantity: 4 mg/ml - eye drops, solution - excipient ingredients: purified water; hydrochloric acid - to produce local anaesthesia in the eye.

Ireland - English - HPRA (Health Products Regulatory Authority)

bausch health ireland limited - oxybuprocaine hydrochloride - eye drops, solution - 0.4 percent weight/volume - local anesthetics; oxybuprocaine

Ireland - English - HPRA (Health Products Regulatory Authority)

bausch + lomb ireland limited - oxybuprocaine hydrochloride - eye drops, solution - local anesthetics; oxybuprocaine

United States - English - NLM (National Library of Medicine)

sintetica sa - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - chloroprocaine hydrochloride 10 mg in 1 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

agepha pharma s.r.o. - oxybuprocaine hydrochloride - eye drops, solution - oxybuprocaine